Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics.
Conclusion: Apremilast initiators had lower healthcare costs even with treatment switching.
PMID: 32638609 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research